This guide explains the Minnesota MPJE as NABP and the Minnesota Board of Pharmacy publish it — the exam’s format and pass/fail scoring, its four competency areas, its fees and attempt rules, the Minnesota law it is answered under, and the March 2027 blueprint change — and how the PassProfessor program maps onto each part.
Format and scoring
The examination presents 120 multiple-choice questions over 2.5 hours at a Pearson VUE test center: 100 scored questions and 20 unscored pretest questions mixed in indistinguishably. Federal and Minnesota questions are intermixed with no distinction made between them — you answer each question under the prevailing law of Minnesota, so where a Minnesota rule differs from the federal rule, the Minnesota rule decides. The result is pass/fail: NABP reports the outcome against its passing standard and does not publish a raw passing score, so no percentage of correct answers can be stated as the passing standard — which is why this program scores practice against a 70% benchmark and labels it as a benchmark. Minnesota law adds no numeric passing score of its own: the licensure statutes and rules require that the examinations be passed and state no number. You may attempt the MPJE up to 5 times per jurisdiction, NABP fees run about $270 per attempt, and the Minnesota Board of Pharmacy confirms your eligibility. MPJE scores are not transferable to other jurisdictions.
The four competency areas
NABP’s current MPJE Competency Statements divide the exam into four areas — and the program mirrors that division exactly:
- Licensure and Personnel — 333 practice questions; 22 per full practice exam
- Pharmacist Practice — 498 practice questions; 33 per full practice exam
- Dispensing Requirements — 358 practice questions; 24 per full practice exam
- Pharmacy Operations — 311 practice questions; 21 per full practice exam
The Minnesota pharmacy law behind the exam
- The Minnesota questions in this bank are grounded in primary Minnesota sources read first-hand: the Pharmacy Practice and Wholesale Distribution Act (Minnesota Statutes, chapter 151), the Board of Pharmacy rules (Minnesota Rules, chapter 6800), the controlled substances chapter (chapter 152) — where the prescription monitoring program statute sits — and the health-occupations framework (chapter 214). Minnesota’s rulebook holds traps that older study materials miss: the monitoring program does not live in the Pharmacy Act at all; the discipline section is § 151.071, while the nearby § 151.061 is an unfair-price-discrimination provision; pharmacy technicians are registered rather than licensed; and the codified internship is 1,600 hours by statute, the older rule text having been repealed. This bank keys on current law throughout, including those changes.
- Minnesota’s prescription monitoring program is the first trap, because its statute is not where most candidates look for it. The program — the system the statute titles the prescription electronic reporting system — lives at § 152.126 in the controlled substances chapter, not in the Pharmacy Act, and the Board of Pharmacy administers it. The statute sets no reporting cadence at all: dispensers submit data within the time frame the Board specifies, and the Board specifies daily reporting — daily is the Board’s specification, not a statutory deadline. What is reportable runs wider than the schedules alone: schedule II through V drugs, substances the Board defines, and butalbital and gabapentin by name — gabapentin is reportable even though Minnesota does not schedule it. Every pharmacist must register for and maintain a program account, but the duty to check the data before prescribing binds prescribers: before the initial schedule II through IV opiate prescription, and at least every three months while such a prescription continues for chronic pain or medication-assisted treatment. There is no check mandate for pharmacists.
- Minnesota schedules drugs at § 152.02 in five schedules that track the federal pattern, with state placements worth knowing cold: pregabalin is a schedule V depressant and tramadol is schedule IV, while gabapentin appears nowhere in the section — it is not a controlled substance under Minnesota law. Controlled-substance prescriptions carry their own rules at § 152.11: photo identification unless the purchaser is known to the pharmacist, documented consent for schedule III and IV prescriptions with a six-month, five-refill ceiling, and acute-pain opiate limits — a seven-day supply for adults, five days for minors, four days for dental and refractive care — that a prescriber’s clinical judgment can override. Substitution runs the other way from most states: it is mandatory, not permissive. Unless the prescriber directs otherwise — ‘dispense as written’ handwritten by the prescriber on a paper prescription, or expressly indicated on an electronic one — the pharmacist shall dispense a less expensive generically equivalent product in stock, telling the purchaser first; if the purchaser objects, the prescribed product is dispensed, a more expensive product is never substituted, and where several interchangeable products are in stock the least expensive is the one dispensed.
- The people rules are Minnesota’s own. The Board of Pharmacy has nine members — six pharmacists, each with at least five consecutive years of experience, and three public members — appointed by the Governor to four-year terms. Licensure begins at eighteen, on good moral character, a degree from an approved college, and a board-prescribed internship: 1,600 hours set by statute, capped at 80 hours in the first year, 400 concurrent hours, and 54 hours in a week; the candidate registers with NABP and passes both the NAPLEX and the MPJE, and even a pharmacist licensed elsewhere must pass the Minnesota MPJE to transfer a license here. Pharmacy technicians are registered, not licensed: they work under a pharmacist’s personal and direct supervision on tasks the rules do not reserve to pharmacists, and certification is not a license tier. Continuing education is thirty hours every two years, with no mandated topics — the Board requires no state-specific continuing education at all. One codified fee — $225 — covers a pharmacist’s application by examination, and the same $225 is the annual renewal; every fee in the bank comes from the fee statute, § 151.065, never from bundled totals on Board forms.
How the program maps to the exam
The PassProfessor Minnesota MPJE program carries 1,500 questions across the four competency areas at their published weights. Practice exams draw 100 scored questions in 150 minutes and are scored against a 70% practice benchmark — a target for your preparation, not the MPJE passing standard, because the real result is pass/fail and NABP publishes no raw passing score. Per-topic drills let you work one competency area at a time, and the free sample exam shows the question style before you enroll.
What changes on March 1, 2027
- From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline — Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, Pharmacy Operations 20%.
- Every question in this bank is dual-tagged to both blueprints, so this program’s practice exams re-weight to the new outline when the change takes effect — the questions you are practicing now stay the right questions.
MPJE scores are not transferable: if you plan to license in more than one MPJE state, plan on that state’s law exam as well. And because every question here is dual-tagged, this program re-weights to the March 2027 outline when it takes effect without the bank changing.